Cellceutix (CTIX) . . . up 10% this morning. Breakthrough cancer treatment starting Phase 1 clinical trials at world's foremost cancer research hospital, Dana Farber this week. Last chance to get in under a buck. Big potential!
(0)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.